Diabetes medications may help lower COPD flare-up risk, study finds

The study reveals SGLT-2is are linked to fewer COPD exacerbations in type 2 diabetes, suggesting a need for further clinical trials to confirm these findings.

In an unusual arrangement, UnitedHealth’s board chair also owns a personal investment firm

Stephen Hemsley, the former CEO of UnitedHealth Group and its current board chair, also owns an investment firm that manages his own portfolio of UnitedHealth

October 18, 2023

Skye Bioscience uplists; OncoX’s licensing deal with ABVC BioPharma

Plus, news about Zevra Therapeutics and YS Biopharma: Skye Bioscience uplists to the Nasdaq: The San Diego biotech $SKYE is set to make the move

April 11, 2024

Iovance’s TIL therapy plus Keytruda show durable treatment effect in melanoma, but access remains a question

Sign up for free to read a limited number of articles each month. Pick what newsletters get delivered to your inbox each week. Biopharma ENDPOINTS

June 2, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.